Benaroya Research Institute

      Jane Buckner, MD, President and Homer W. Lane, Jr., Executive Director and CFO
Jane Buckner, MD, President; Homer Lane, Jr., Executive Director and Chief Financial Officer

Dear Friends,

Our pioneering vision for the future is firmly grounded in the innovative breakthroughs we’ve made in more than 30 years of immunology research at Benaroya Research Institute at Virginia Mason (BRI).

We envision a world where our knowledge of the immune system is harnessed to return people with chronic diseases, such as multiple sclerosis, rheumatoid arthritis, type 1 diabetes, allergies and asthma, back to health and ultimately to prevent these diseases from ever taking hold. Through our groundbreaking research, we are committed to understanding or decoding the immune system to prevent and cure these diseases for our patients and their families.

At BRI our approach is unique. We are tackling autoimmunity and allergic disease as a whole, because they are all connected. There are more than 80 autoimmune diseases and we know that progress against one is progress against them all. We have created the right team for the fight. Our outstanding faculty and scientists work relentlessly to discover the causes of autoimmune and allergic diseases. Yet discovery is just the beginning. We’re seeking prevention. We’re seeking cures. We do this by creating an environment where scientists, physicians and research participants can work together to translate breakthroughs in the lab into meaningful treatments for patients and their families.

Our organization is strongly positioned to take on this ambitious mission. In 2016, our research revenue grew to $75 million, up from $65 million in 2015. We received 23 new grants in a variety of immune disease areas. Currently, we rank third in Washington state for funding from the National Institutes of Health. We are leaders of four international autoimmune diseases research networks.

Our success wouldn’t be possible without community support. Federal and private grants don’t cover the full cost of conducting research. Donations from individuals and organizations provide vital funds for initiating innovative research projects, bringing on new scientists and purchasing leading-edge equipment. For every $1 donated to BRI, historically we generate an additional $6 in research funding. Besides counting on ongoing contributions, BRI is also securing the future by increasing endowment funds. Recently endowed chairs will generate long-term reserves for five major research areas.

We couldn’t achieve this life-saving work without our research participants, volunteers, donors, board members, research sponsors, collaborators and partner organizations. We thank you for your ongoing support and investment in our vision to improve the lives of people suffering from autoimmune diseases.

Benaroya Research Institute Annual Report

Sincerely,

Jane H. Buckner, MD
President
Benaroya Research Institute

Homer W. Lane, Jr.
Executive Director and Chief Financial Officer
Benaroya Research Institute